Robustness of brain tumor segmentation.

J Med Imaging (Bellingham)

Saarland University Medical Center, Department of Pediatric Oncology and Hematology, Homburg, Germany.

Published: November 2020

The segmentation of brain tumors is one of the most active areas of medical image analysis. While current methods perform superhuman on benchmark data sets, their applicability in daily clinical practice has not been evaluated. In this work, we investigate the generalization behavior of deep neural networks in this scenario. We evaluate the performance of three state-of-the-art methods, a basic U-Net architecture, and a cascadic Mumford-Shah approach. We also propose two simple modifications (which do not change the topology) to improve generalization performance. In these experiments, we show that a well-trained U-network shows the best generalization behavior and is sufficient to solve this segmentation problem. We illustrate why extensions of this model in a realistic scenario can be not only pointless but even harmful. We conclude from these experiments that the generalization performance of deep neural networks is severely limited in medical image analysis especially in the area of brain tumor segmentation. In our opinion, current topologies are optimized for the actual benchmark data set but are not directly applicable in daily clinical practice.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773029PMC
http://dx.doi.org/10.1117/1.JMI.7.6.064006DOI Listing

Publication Analysis

Top Keywords

brain tumor
8
tumor segmentation
8
medical image
8
image analysis
8
benchmark data
8
daily clinical
8
clinical practice
8
generalization behavior
8
deep neural
8
neural networks
8

Similar Publications

Minimally invasive parafascicular surgery (MIPS) with the use of tubular retractors achieve a safe resection in deep seated tumours. Diffusion changes noted on postoperative imaging; the significance and clinical correlation of this remains poorly understood. Single centre retrospective cohort study of neuro-oncology patients undergoing MIPS.

View Article and Find Full Text PDF

Progress report on multiple endocrine neoplasia type 1.

Fam Cancer

January 2025

Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Multiple endocrine neoplasia type 1 (MEN1) syndrome is an autosomal dominant disorder caused by a germline pathogenic variant in the MEN1 tumor suppressor gene. Patients with MEN1 have a high risk for primary hyperparathyroidism (PHPT) with a penetrance of nearly 100%, pituitary adenomas (PitAd) in 40% of patients, and neuroendocrine neoplasms (NEN) of the pancreas (40% of patients), duodenum, lung, and thymus. Increased MEN1-related mortality is mainly related to duodenal-pancreatic and thymic NEN.

View Article and Find Full Text PDF

Background: Resistance to temozolomide (TMZ) remains is an important cause of treatment failure in patients with glioblastoma multiforme (GBM). ADAR1, as a member of the ADAR family, plays an important role in cancer progression and chemotherapy resistance. However, the mechanism by which ADAR1 regulates GBM progression and TMZ resistance is still unclear.

View Article and Find Full Text PDF

The development of deep learning algorithms has transformed medical image analysis, especially in brain tumor recognition. This research introduces a robust automatic microbrain tumor identification method utilizing the VGG16 deep learning model. Microscopy magnetic resonance imaging (MMRI) scans extract detailed features, providing multi-modal insights.

View Article and Find Full Text PDF

The transcriptomic classification of primary colorectal cancer (CRC) into distinct consensus molecular subtypes (CMSs) is a well-described strategy for patient stratification. However, the molecular nature of CRC metastases remains poorly investigated. To this end, this study aimed to identify and compare organotropic CMS frequencies in CRC liver and brain metastases.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!